The primary aim of this trial was to evaluate if a strict glucose intervention with insulin infusion monitored with a hybrid approach of isCGM and periodic POC is safe, practical, and beneficial in a surgical, non-ICU ward setting during TPN-induced hyperglycaemia. This evidence concerns the gene INS and Hyperglycemia.